Lonza Group (XSWX:LONN) FFO


XSWX:LONN Lonza Group Ltd XSWX:LONN
81 GF Score
Price CHF539.60
GF Value CHF592.82
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Lonza Group FFO?

FFO (Funds from operations) only applies to REITs.

XSWX:LONN
81GF Score
Lonza Group Ltd XSWX:LONN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lonza Group (XSWX:LONN) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of CHF539.60 is trading 9% below its estimated GF Value™ of CHF592.82. GuruFocus considers Lonza Group to be Fairly Valued.

Key valuation signals for XSWX:LONN:

  • FFO:
  • GF Value™: CHF592.82 vs. price of CHF539.60 (9% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:LONN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
81GF Score

Get the complete analysis for XSWX:LONN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF539.60
Price
CHF592.82
GF Value